Translational Development: Bridging Preclinical Findings to Clinical Success in Claudin-Targeted Therapies
Time: 12:45 pm
day: Conference Day 2
Details:
- Understanding the importance of developing companion diagnostics for Claudintargeted therapies, including the identification and validation of biomarkers to ensure patient selection
- Showcasing strategies to address challenges in translational development, such as achieving target specificity, managing toxicity profiles, and optimizing therapeutic windows
- Analyzing case studies highlighting the successful transition of Claudin-targeted therapies from preclinical stages to clinical trials, with a focus on lessons learned and best practices
